| 1 |
Bartoloni E, Baldini C, Schillaci G, et al. Cardiovascular disease risk burden in primary Sjögren’s syndrome: results of a population-based multicentre cohort study[J]. J Intern Med, 2015, 278(2): 185-192.
|
| 2 |
Bartoloni E, Alunno A, Bistoni O, et al. Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren’s syndrome: new markers of chronic endothelial damage[J]. Rheumatology (Oxford), 2015, 54(3): 536-544.
|
| 3 |
Sezis Demirci M, Karabulut G, Gungor O, et al. Is there an increased arterial stiffness in patients with primary Sjögren’s syndrome[J]. Intern Med, 2016, 55(5): 455-459.
|
| 4 |
李伟, 李少武, 张在强. 原发性干燥综合征继发中枢神经系统血管炎临床及影像分析[J]. 中国卒中杂志, 2015, 10(5): 407-412.
|
|
Li W, Li SW, Zhang ZQ. Clinical and imaging characteristics of secondary central nervous system vasculitis cau-sed by primary Sjögren’s syndrome[J]. Chin J Stroke, 2015, 10(5): 407-412.
|
| 5 |
宣磊, 屈洋, 董振华. 原发性干燥综合征皮肤黏膜损害[J]. 中华临床免疫和变态反应杂志, 2015, 9(3): 218-221.
|
|
Xuan L, Qu Y, Dong ZH. Damage of skin and mucosamembrane in primary Sjögren’s syndrome[J]. Chin J All Clin Immunol, 2015, 9(3): 218-221.
|
| 6 |
汤建平. 干燥综合征的血液系统损害与治疗对策[J/CD]. 中华临床医师杂志(电子版), 2013, 7(7): 2768-2770.
|
|
Tang JP. The damage of blood system in Sjögren’s syndrome and its treatment[J/CD]. Chin J Clin (Electr Ed), 2013, 7(7): 2768-2770.
|
| 7 |
Elad S, Zadik Y, Yarom N. Oral complications of non-surgical cancer therapies[J]. Atlas Oral Maxillofac Surg Clin North Am, 2017, 25(2): 133-147.
|
| 8 |
Sonis ST. Oral mucositis in head and neck cancer: risk, biology, and management[J]. Am Soc Clin Oncol Educ Book, 2013, doi: 10.1200/edbook_am.2013.33.e236 .
|
| 9 |
Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis[J]. Head Neck, 2004, 26(1): 77-84.
|
| 10 |
程斌, 李春阳, 夏娟. 放射性口腔黏膜炎诊断与治疗[J]. 中国实用口腔科杂志, 2008, 1(9): 513-516.
|
|
Cheng B, Li CY, Xia J. Diagnosis and treatment of radiation-induced oral mucositis[J]. Chin J Pract Stomatol, 2008, 1(9): 513-516.
|
| 11 |
Richards TM, Hurley T, Grove L, et al. The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures[J]. Oral Dis, 2017, 23(7): 990-1000.
|
| 12 |
Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis[J]. Head Neck, 2003, 25(12): 1057-1070.
|
| 13 |
Wollina U, Schönlebe J, Koch A, et al. Atypical vascu-lar proliferations of the neck[J]. Wien Med Wochenschr, 2021, 171(3/4): 57-60.
|
| 14 |
蔡俊娜, 卿松, 成宇帆, 等. 乳腺癌保乳术及放疗后非典型性血管病变的病理特征[J]. 临床与实验病理学杂志, 2010, 26(1): 40-45.
|
|
Cai JN, Qing S, Cheng YF, et al. A typical vascular lesions after conservative surgery and radiation of breast cancer: report of a case and review of the literature[J]. J Clin Exp Pathol, 2010, 26(1): 40-45.
|
| 15 |
Sheibani KM, Mafi AR, Moghaddam S, et al. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: a double-blind placebo-controlled randomized clinical trial[J]. Asia Pac J Clin Oncol, 2015, 11(1): 22-27.
|
| 16 |
Anoopkumar-Dukie S, Conere T, Houston A, et al. The COX-2 inhibitor NS398 selectively sensitizes hypoxic HeLa cells to ionising radiation by mechanisms both dependent and independent of COX-2[J]. Prostaglandins Other Lipid Mediat, 2020, 148: 106422.
|
| 17 |
Wei J, Wang B, Wang H, et al. Radiation-induced normal tissue damage: oxidative stress and epigenetic mechanisms[J]. Oxid Med Cell Longev, 2019, 2019: 3010342.
|
| 18 |
Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy[J]. Acta Pharm Sin B, 2015, 5(5): 378-389.
|
| 19 |
Banys-Paluchowski M, Witzel I, Riethdorf S, et al. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer[J]. Breast Cancer Res Treat, 2018, 172(1): 93-104.
|
| 20 |
Wang X, Tao T, Song D, et al. Calreticulin stabilizes F-actin by acetylating actin and protects microvascular endothelial cells against microwave radiation[J]. Life Sci, 2019, 232: 116591.
|
| 21 |
Baselet B, Sonveaux P, Baatout S, et al. Pathological effects of ionizing radiation: endothelial activation and dysfunction[J]. Cell Mol Life Sci, 2019, 76(4): 699-728.
|
| 22 |
Fernández-Alvarez V, López F, Suárez C, et al. Radiation-induced carotid artery lesions[J]. Strahlenther On-kol, 2018, 194(8): 699-710.
|
| 23 |
Pueyo G, Mesia R, Figueras A, et al. Cetuximab may inhibit tumor growth and angiogenesis induced by ioni-zing radiation: a preclinical rationale for maintenance treatment after radiotherapy[J]. Oncologist, 2010, 15(9): 976-986.
|
| 24 |
Koukourakis MI, Koukourakis IM, Arelaki S, et al. Angiogenic regeneration defines loco-regional recurrence following pre-operative radio-chemotherapy for rectal cancer: a pilot study[J]. Mol Biol Rep, 2019, 46(2): 2147-2152.
|
| 25 |
Pulito C, Cristaudo A, Porta C, et al. Oral mucositis: the hidden side of cancer therapy[J]. J Exp Clin Cancer Res, 2020, 39(1): 210.
|
| 26 |
李宇鑫, 周露, 郭旦, 等. 沙利度胺预防鼻咽癌放射性口腔粘膜炎的效果及对患者血清TNF-α的影响[J]. 医学信息, 2021, 34(1): 149-151, 154.
|
|
Li YX, Zhou L, Guo D, et al. The effect of thalidomide in preventing radiation-induced oral mucositis of nasopharyngeal carcinoma and its influence on patients’ serum TNF-α[J]. Med Info, 2021, 34(1): 149-151, 154.
|
| 27 |
Frings K, Gruber S, Kuess P, et al. Modulation of radiation-induced oral mucositis by thalidomide: preclinical studies[J]. Strahlenther Onkol, 2016, 192(8): 561-568.
|
| 28 |
Liang L, Chen L, Liu G, et al. Thalidomide attenuates oral epithelial cell apoptosis and pro-inflammatory cytokines secretion induced by radiotherapy via the miR-9-3p/NFATC2/NF-κB axis[J]. Biochem Biophys Res Commun, 2022, 603: 102-108.
|
), 陈谦明, 江潞(
